spacer
spacer
Go to PDB code: 
protein ligands Protein-protein interface(s) links
Hydrolase/immune system PDB-id
1bzq
Asymmetric unit
    Jmol     Help!  
Contents
Description
Header details
Header records
References
PROCHECK
Protein chains
124 a.a. *
124 a.a. *
Ligands
PO4 ×4

* Residue conservation analysis
Tools
Image Generation
AstexViewer™@PDBe
Run PROCHECK
Clefts Calculation
  
  Biological unit*, octamer
(*as deduced by PQS)
PDB id: 1bzq
Name: Hydrolase/immune system
Title: Complex of a dromedary single-domain vhh antibody fragment with rnase a

Structure:
Protein (rnase a). Chain: a, b, c, d. Protein (antibody cab-rn05). Chain: k, l, m, n. Fragment: variable domain. Engineered: yes

Source:
Bos taurus. Cattle. Organism_taxid: 9913. Organ: pancreas. Other_details: rnase a supplied by sigma. Camelus dromedarius. Arabian camel. Organism_taxid: 9838. Cell: b-lymphocytes.

Biological unit:
Octamer (from PQS)

UniProt:
Chains A, B, C, D: P61823 (RNAS1_BOVIN)
Pfam   ArchSchema ?
Seq: 150 a.a.
Struc: 124 a.a.
Key:    PfamA domain
 Secondary structure  CATH domain

Enzyme class:
Chains A, B, C, D: E.C.3.1.27.5   [IntEnz]   [ExPASy]   [KEGG]   [BRENDA]

Reaction:
Endonucleolytic cleavage to nucleoside 3'-phosphates and 3'-phosphooligonucleotides ending in C-P or U-P with 2',3'-cyclic phosphate intermediates.

Resolution:
2.80Å

R-factor:
0.222

R-free:
0.282

Authors:
K.Decanniere,A.Desmyter,M.Gahroudhi,M.Lauwereys, S.Muyldermans,L.Wyns

Key ref:
K.Decanniere et al. (1999). A single-domain antibody fragment in complex with RNase A: non-canonical loop structures and nanomolar affinity using two CDR loops.. Structure, 7, 361-370. [PubMed id: 10196124] [DOI: 10.1016/S0969-2126(99)80049-5]

Date:
03-Nov-98

Release date:
11-Nov-98
Quick_links
RCSB
PDBe
SRS
MMDB
JenaLib
OCA
PDBWiki
Proteopedia
CATH
SCOP
FSSP
HSSP
PDBSWS
PQS
CSA
ProSAT
Whatcheck
EDS
Procheck
Go to PROCHECK summary
Surface
RasMol surface
spacer
spacer

 
    Key reference    
 
 
DOI no: 10.1016/S0969-2126(99)80049-5 Structure 7:361-370 (1999)
PubMed id: 10196124  
 
 
A single-domain antibody fragment in complex with RNase A: non-canonical loop structures and nanomolar affinity using two CDR loops.
K.Decanniere, A.Desmyter, M.Lauwereys, M.A.Ghahroudi, S.Muyldermans, L.Wyns.
 
  ABSTRACT  
 
BACKGROUND: Camelid serum contains a large fraction of functional heavy-chain antibodies - homodimers of heavy chains without light chains. The variable domains of these heavy-chain antibodies (VHH) have a long complementarity determining region 3 (CDR3) loop that compensates for the absence of the antigen-binding loops of the variable light chains (VL). In the case of the VHH fragment cAb-Lys3, part of the 24 amino acid long CDR3 loop protrudes from the antigen-binding surface and inserts into the active-site cleft of its antigen, rendering cAb-Lys3 a competitive enzyme inhibitor. RESULTS: A dromedary VHH with specificity for bovine RNase A, cAb-RN05, has a short CDR3 loop of 12 amino acids and is not a competitive enzyme inhibitor. The structure of the cAb-RN05-RNase A complex has been solved at 2.8 A. The VHH scaffold architecture is close to that of a human VH (variable heavy chain). The structure of the antigen-binding hypervariable 1 loop (H1) of both cAb-RN05 and cAb-Lys3 differ from the known canonical structures; in addition these H1 loops resemble each other. The CDR3 provides an antigen-binding surface and shields the face of the domain that interacts with VL in conventional antibodies. CONCLUSIONS: VHHs adopt the common immunoglobulin fold of variable domains, but the antigen-binding loops deviate from the predicted canonical structure. We define a new canonical structure for the H1 loop of immunoglobulins, with cAb-RN05 and cAb-Lys3 as reference structures. This new loop structure might also occur in human or mouse VH domains. Surprisingly, only two loops are involved in antigen recognition; the CDR2 does not participate. Nevertheless, the antigen binding occurs with nanomolar affinities because of a preferential usage of mainchain atoms for antigen interaction.
 
  Selected figure(s)  
 
Figure 5.
Figure 5. Stereoview of the overlap of non-bulged torso CDR3 reference structure (PDB entry code 1flr [32], in blue) and the CDR3 of cAb-RN05 (yellow). Only the backbone atoms are shown for clarity. The hydrogen-bonding pattern of the reference structure is indicated by dotted lines. The position of amino acid residues 92, 97, 99 and 104 are indicated for reference. The figure was generated with SETOR [41].
 
  The above figure is reprinted by permission from Cell Press: Structure (1999, 7, 361-370) copyright 1999.  
  Figure was selected by the author.  

Literature references that cite this PDB file's key reference

  PubMed id Reference
19010777 C.Vincke, R.Loris, D.Saerens, S.Martinez-Rodriguez, S.Muyldermans, and K.Conrath (2009).
General Strategy to Humanize a Camelid Single-domain Antibody and Identification of a Universal Humanized Nanobody Scaffold.
  J Biol Chem, 284, 3273-3284.
PDB codes: 3dwt 3eak 3eba
19033278 M.Arbabi-Ghahroudi, R.To, N.Gaudette, T.Hirama, W.Ding, R.MacKenzie, and J.Tanha (2009).
Aggregation-resistant VHs selected by in vitro evolution tend to have disulfide-bonded loops and acidic isoelectric points.
  Protein Eng Des Sel, 22, 59-66.  
19089973 N.Wang, W.F.Smith, B.R.Miller, D.Aivazian, A.A.Lugovskoy, M.E.Reff, S.M.Glaser, L.J.Croner, and S.J.Demarest (2009).
Conserved amino acid networks involved in antibody variable domain interactions.
  Proteins, 76, 99.  
17932913 D.P.Simmons, V.A.Streltsov, O.Dolezal, P.J.Hudson, A.M.Coley, M.Foley, D.F.Proll, and S.D.Nuttall (2008).
Shark IgNAR antibody mimotopes target a murine immunoglobulin through extended CDR3 loop structures.
  Proteins, 71, 119-130.
PDB codes: 2ywy 2ywz
18045863 P.A.Barthelemy, H.Raab, B.A.Appleton, C.J.Bond, P.Wu, C.Wiesmann, and S.S.Sidhu (2008).
Comprehensive Analysis of the Factors Contributing to the Stability and Solubility of Autonomous Human VH Domains.
  J Biol Chem, 283, 3639-3654.
PDB code: 3b9v
18445622 V.Tereshko, S.Uysal, A.Koide, K.Margalef, S.Koide, and A.A.Kossiakoff (2008).
Toward chaperone-assisted crystallography: protein engineering enhancement of crystal packing and X-ray phasing capabilities of a camelid single-domain antibody (VHH) scaffold.
  Protein Sci, 17, 1175-1187.
PDB codes: 2p42 2p43 2p44 2p45 2p46 2p47 2p48
17420456 A.Koide, R.N.Gilbreth, K.Esaki, V.Tereshko, and S.Koide (2007).
High-affinity single-domain binding proteins with a binary-code interface.
  Proc Natl Acad Sci U S A, 104, 6632-6637.
PDB code: 2obg
17322532 C.A.Olson, and R.W.Roberts (2007).
Design, expression, and stability of a diverse protein library based on the human fibronectin type III domain.
  Protein Sci, 16, 476-484.  
15659390 E.De Genst, K.Silence, M.A.Ghahroudi, K.Decanniere, R.Loris, J.Kinne, L.Wyns, and S.Muyldermans (2005).
Strong in vivo maturation compensates for structurally restricted H3 loops in antibody repertoires.
  J Biol Chem, 280, 14114-14121.
PDB codes: 1ri8 1rjc
15709914 H.Revets, P.De Baetselier, and S.Muyldermans (2005).
Nanobodies as novel agents for cancer therapy.
  Expert Opin Biol Ther, 5, 111-124.  
16408159 M.Arbabi-Ghahroudi, J.Tanha, and R.MacKenzie (2005).
Prokaryotic expression of antibodies.
  Cancer Metastasis Rev, 24, 501-519.  
15378291 V.Joosten, R.J.Gouka, C.A.van den Hondel, C.T.Verrips, and B.C.Lokman (2005).
Expression and production of llama variable heavy-chain antibody fragments (V(HH)s) by Aspergillus awamori.
  Appl Microbiol Biotechnol, 66, 384-392.  
15130125 E.Veiga, V.de Lorenzo, and L.A.Fernández (2004).
Structural tolerance of bacterial autotransporters for folded passenger protein domains.
  Mol Microbiol, 52, 1069-1080.  
15319492 R.L.Stanfield, H.Dooley, M.F.Flajnik, and I.A.Wilson (2004).
Crystal structure of a shark single-domain antibody V region in complex with lysozyme.
  Science, 305, 1770-1773.
PDB codes: 1sq2 1t6v
12533537 J.Lah, I.Marianovsky, G.Glaser, H.Engelberg-Kulka, J.Kinne, L.Wyns, and R.Loris (2003).
Recognition of the intrinsically flexible addiction antidote MazE by a dromedary single domain antibody fragment. Structure, thermodynamics of binding, stability, and influence on interactions with DNA.
  J Biol Chem, 278, 14101-14111.  
12548621 M.K.Fenwick, and F.A.Escobedo (2003).
Hybrid Monte Carlo with multidimensional replica exchanges: conformational equilibria of the hypervariable regions of a llama VHH antibody domain.
  Biopolymers, 68, 160-177.  
12831531 R.J.Olsen, J.Mazlo, S.A.Koepsell, T.W.McKeithan, and S.H.Hinrichs (2003).
Minimal structural elements of an inhibitory anti-ATF1/CREB single-chain antibody fragment (scFv41.4).
  Hybrid Hybridomics, 22, 65-77.  
12743116 R.Loris, I.Marianovsky, J.Lah, T.Laeremans, H.Engelberg-Kulka, G.Glaser, S.Muyldermans, and L.Wyns (2003).
Crystal structure of the intrinsically flexible addiction antidote MazE.
  J Biol Chem, 278, 28252-28257.
PDB code: 1mvf
11960990 A.Desmyter, S.Spinelli, F.Payan, M.Lauwereys, L.Wyns, S.Muyldermans, and C.Cambillau (2002).
Three camelid VHH domains in complex with porcine pancreatic alpha-amylase. Inhibition and versatility of binding topology.
  J Biol Chem, 277, 23645-23650.
PDB codes: 1kxq 1kxt 1kxv
11141058 J.M.Pérez, J.G.Renisio, J.J.Prompers, C.J.van Platerink, C.Cambillau, H.Darbon, and L.G.Frenken (2001).
Thermal unfolding of a llama antibody fragment: a two-state reversible process.
  Biochemistry, 40, 74-83.  
10931555 A.Skerra (2000).
Engineered protein scaffolds for molecular recognition.
  J Mol Recognit, 13, 167-187.  
11701516 J.Maynard, and G.Georgiou (2000).
Antibody engineering.
  Annu Rev Biomed Eng, 2, 339-376.  
10684599 S.Spinelli, L.G.Frenken, P.Hermans, T.Verrips, K.Brown, M.Tegoni, and C.Cambillau (2000).
Camelid heavy-chain variable domains provide efficient combining sites to haptens.
  Biochemistry, 39, 1217-1222.
PDB code: 1qd0
10698934 V.K.Nguyen, R.Hamers, L.Wyns, and S.Muyldermans (2000).
Camel heavy-chain antibodies: diverse germline V(H)H and specific mechanisms enlarge the antigen-binding repertoire.
  EMBO J, 19, 921-930.  
The most recent references are shown first. Citation data come partly from CiteXplore and partly from an automated harvesting procedure. Note that this is likely to be only a partial list as not all journals are covered by either method. However, we are continually building up the citation data so more and more references will be included with time. Where a reference describes a PDB structure, the PDB codes are shown on the right.